Sign Up to like & get
recommendations!
0
Published in 2018 at "Head and Neck Pathology"
DOI: 10.1007/s12105-018-0951-1
Abstract: Human papillomavirus (HPV)-related multiphenotypic sinonasal carcinoma (HMSC) is a distinct, newly-described sinonasal tract neoplasm characterized by a salivary gland tumor-like appearance with myoepithelial and ductal cells, frequent surface squamous dysplasia, and relatively indolent behavior. When…
read more here.
Keywords:
lef;
multiphenotypic sinonasal;
related multiphenotypic;
expression ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Delivery"
DOI: 10.1080/10717544.2022.2079770
Abstract: Abstract Despite the fact of availability of several treatments for breast cancer, most of them fail to attain the desired therapeutic response due to their poor bioavailability, high doses, non-selectivity and as a result systemic…
read more here.
Keywords:
leflunomide;
lef;
breast cancer;
cancer management ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofy210.1196
Abstract: Abstract Background LEF, a novel pleuromutilin antibiotic for IV and oral use, recently completed a phase 3 trial for the treatment of CABP in adults where it demonstrated noninferiority to moxifloxacin ± linezolid. LEF selectively…
read more here.
Keywords:
shareholder;
lef;
vitro activity;
cabp ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.2751
Abstract: Background Glucocorticoids (GC) have been the mainstay treatment in giant cell arteritis (GCA) for decades. Recently tocilizumab and abatacept have been proven to be effective alternatives to glucocortiocids. However, not all GCA patients are eligible…
read more here.
Keywords:
giant cell;
lef;
treatment;
cell arteritis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.3463
Abstract: Background: RA is associated with an increased cardiovascular (CV) risk. csDMARDs are first-line treatments for RA and can mitigate this risk, but limited data exist on their CV effects. Previous trials have reported protective effects…
read more here.
Keywords:
hcq;
mtx;
risk;
lef ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/2040622320922019
Abstract: Aims: The objective of this study was to investigate the outcomes of leflunomide (LEF) compared with those of cyclophosphamide (CYC) as induction against active Takayasu’s arteritis (TA) in Chinese patients. Methods: This was an observational…
read more here.
Keywords:
lef;
study;
compared cyclophosphamide;
induction ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/2040622320975233
Abstract: Aims: The study investigates the effectiveness and safety of methotrexate (MTX) versus leflunomide (LEF) in 12-month treatment of Takayasu arteritis (TAK). Methods: This was a cohort study. Patients diagnosed with TAK between 1 January 2013…
read more here.
Keywords:
effectiveness safety;
lef;
treatment;
group ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.941215
Abstract: Diabetic kidney disease (DKD) combined with Membranous Nephropathy (MN) was observed in some patients with the increasing of Diabetic patients. However, no treatment guidelines are available for DKD combined with MN. In this study, we…
read more here.
Keywords:
dkd;
lef group;
lef;
treatment ... See more keywords